Evidence map›Paper›PMID 30823649›Full record

ReviewInternational journal of molecular sciences2019

Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.

Teodora Costea, Péter Nagy, Constanța Ganea, János Szöllősi, Maria-Magdalena Mocanu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Lemur Tyrosine Kinases and Prostate Cancer: A Literature Review.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Teodora CosteaDepartment of Pharmacognosy, Phytochemistry and Phytotherapy, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. teodora.costea@umfcd.ro.
Péter NagyDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. nagyp@med.unideb.hu.
Constanța GaneaDepartment of Biophysics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. constanta.ganea@gmail.com.
János SzöllősiDepartment of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. szollo@med.unideb.hu.
Maria-Magdalena MocanuDepartment of Biophysics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. magda.mocanu@umfcd.ro.
Carol Davila University of Medicine and Pharmacy · ROUniversity of Debrecen · HU

Funding

National Research, Development and Innovation Office, Hungary K120302, GINOP-2.3.2-15-2016-00020, GINOP-2.3.2-15-2016-00044, GINOP-2.3.3-15-2016-0003
6 · The paper itself

Abstract

Prostate cancer is the one of the most frequently diagnosed cancers among men over the age of 50. Several lines of evidence support the observation that polyphenols have preventive and therapeutic effects in prostate cancer. Moreover, prostate cancer is ideal for chemoprevention due to its long latency. We propose here an equilibrated lifestyle with a diet rich in polyphenols as prophylactic attempts to slow down the progression of localized prostate cancer or prevent the occurrence of the disease. In this review, we will first summarize the molecular mechanisms of polyphenols in prostate cancer with a focus on the antioxidant and pro-oxidant effects, androgen receptors (AR), key molecules involved in AR signaling and their transactivation pathways, cell cycle, apoptosis, angiogenesis, metastasis, genetic aspects, and epigenetic mechanisms. The relevance of the molecular mechanisms is discussed in light of current bioavailability data regarding the activity of polyphenols in prostate cancer. We also highlight strategies for improving the bioavailability of polyphenols. We hope that this review will lead to further research regarding the bioavailability and the role of polyphenols in prostate cancer prevention and treatment.

Indexed as

AnimalsAntineoplastic AgentsBiological AvailabilityHumansMalePolyphenolsProstatic NeoplasmsAntineoplastic AgentsPolyphenolsbioavailabilitydietary polyphenolsmolecular mechanismsprostate cancer

Identifiers

PMID30823649
PMCPMC6429226
OpenAlexW2920231883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.